News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LAPALME PIERRE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/23/2019 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 16,000 options to buy
@ $8.06, valued at
$129k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 16,000 options to buy
@ $8.06, valued at
$129k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 05/10/2018 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Disposed/sold 4,000 restricted stock units
@ $0 |
|
| 02/23/2017 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc. |
| 05/04/2016 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $14.44, valued at
$361k
|
|
| 06/18/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/07/2015 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $53.5, valued at
$481.5k
|
|
| 03/05/2015 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 20,000 shares
@ $106.57, valued at
$2.1M
Exercised 10,000 options to buy
@ $11.15, valued at
$111.5k
Exercised 10,000 options to buy
@ $17.33, valued at
$173.3k
|
|
| 08/11/2014 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $27.14, valued at
$244.3k
|
|
| 06/06/2014 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 2,100 shares
@ $0
Granted 6,600 options to buy
@ $63.1, valued at
$416.5k
|
|
| 05/28/2013 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $10.3879, valued at
$20.8k
Bought 1,000 shares
@ $10.3945, valued at
$10.4k
|
|
| 05/17/2013 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 3,400 shares
@ $0
Granted 8,500 options to buy
@ $67.81, valued at
$576.4k
|
|
| 05/16/2013 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.89, valued at
$217.8k
|
|
| 05/02/2013 |
3
| LAPALME PIERRE (Director) has filed a Form 3 on Insys Therapeutics, Inc. |
| 02/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/10/2012 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 3,400 shares
@ $0
Granted 8,500 options to buy
@ $37.46, valued at
$318.4k
|
|
| 03/01/2012 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 20,000 shares
@ $36.0053, valued at
$720.1k
Exercised 20,000 options to buy
@ $8.47, valued at
$169.4k
|
|
| 05/16/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2011 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 100 shares
@ $26, valued at
$2.6k
Sold 15,000 shares
@ $24.9397, valued at
$374.1k
Exercised 100 options to buy
@ $8.47, valued at
$847
Exercised 15,000 options to buy
@ $5.92, valued at
$88.8k
|
|
| 05/14/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2009 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC |
| 05/14/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 12/04/2008 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 02/12/2003 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 02/13/2002 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 02/13/2001 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
|
|